Thus, a dual modulator, the structures of a curcumin-based analogue, as GSK-3β inhibitor, and a diethyl fumarate fragment, as Nrf2 inducer, could be effective in PD [59]. This evidence concerns the gene NFE2L2 and Parkinson disease.